Related Experiment Video
Updated: Mar 16, 2026

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Results of peripheral bypass surgery in patients with critical limb ischemia (CRITISCH registry)
T Bisdas1, G Torsello1, A Stachmann1
1Klinik für Vaskuläre und Endovaskuläre Chirurgie, Universitätsklinikum and St. Franziskus Hospital Münster, Münster, Germany.
Insights
For critical limb ischemia (CLI) bypasses above the knee, synthetic grafts are comparable to vein grafts. However, for more distal bypasses, vein grafts demonstrate superior amputation-free survival rates.
Area of Science:
- Vascular Surgery
- Reconstructive Surgery
- Critical Limb Ischemia (CLI)
Background:
- Critical Limb Ischemia (CLI) poses a significant risk for limb loss.
- Lower extremity bypass surgery is a key intervention for CLI.
- The choice of bypass material and anastomosis site impacts outcomes.
Purpose of the Study:
- To analyze outcomes of lower extremity bypass surgery in CLI patients.
- To compare bypass materials (vein vs. synthetic grafts) based on distal anastomosis site.
- To evaluate amputation-free survival and perioperative complications.
Main Methods:
- Retrospective analysis of 284 CLI patients from the CRITISCH registry.
- Patients categorized by distal anastomosis: above knee (Group 1), below knee (Group 2), crural/pedal (Group 3).
- Comparison of autologous saphenous vein grafts (n=159) versus synthetic grafts (n=125).
Main Results:
- Amputation-free survival at 1 year was 86% (Group 1), 65% (Group 2), and 69% (Group 3).
- Above-knee bypasses: synthetic grafts showed similar amputation-free survival (92%) compared to vein grafts (71%).
- Crural/pedal bypasses: vein grafts yielded better 1-year amputation-free survival (76%) than synthetic grafts (56%).
Conclusions:
- For above-knee bypasses in CLI patients, synthetic grafts are non-inferior to vein grafts at 1-year follow-up.
- Vein grafts are preferable for more distal anastomoses (below knee, crural/pedal) to improve amputation-free survival.
- Lower PREVENT III (PIII) CLI risk scores and Rutherford class correlate with better outcomes.
Aim:
On the basis of the CRITISCH registry outcomes in patients with critical limb ischemia (CLI) undergoing lower extremity bypass surgery were analyzed according to the site of distal anastomosis and type of bypass material.
Patients And Methods:
A total of 284 patients with lower extremity bypasses consisting of 75 patients with bypasses above the knee (group 1), 80 with bypasses below the knee (group 2) and 129 crural or pedal bypasses (group 3) were included in the study. Altogether, 159 autologous saphenous vein grafts and 125 synthetic grafts were used.
Results:
There were no perioperative complications in 191 out of the 284 patients (67.3 %) and 236 of the 284 patients (83.1 %) had open bypasses at hospital discharge. An uneventful postoperative course was observed in 76 % of the patients in group 1, 62.5 % in group 2 and 65.1 % in group 3. Amputation-free survival was 86 % at 1 year in group 1, 65 % in group 2 and 69 % in group 3. For bypasses above the knee synthetic grafts were at least not inferior to vein grafts (amputation-free survival at 1 year: prosthetic bypasses 92 % and saphenous vein grafts 71 %, p = 0.147), whereas in the crural/pedal bypass group vein grafts showed better amputation-free survival at 1 year (76 %) compared with synthetic bypasses (56 %, p = 0.105). Patients with a PREVENT III (PIII) CLI risk score ≤3 exhibited better amputation-free survival at 1 year (78 %) compared to patients with a PIII CLI risk score of 4-7 (69 %, p = 0.053). The same applied to patients with Rutherford class 4 vs. Rutherford class 6 CLI.
Conclusion:
In patients with CLI and above-knee bypasses, vein grafts confer no benefits compared with synthetic grafts for at least 1 year follow-up; however, in the case of more distal anastomoses vein grafts should be preferred.
Related Concept Videos
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Artery Disease III: Interprofessional Care
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease IV: Nursing Management
Peripheral Artery Disease I: Introduction

